O T C
Nutra Pharma is Excited to Announce: Luxury Feet now Available on Amazon

Nutra Pharma is announcing their newest product, Luxury Feet; is now available for purchase on Amazon.com   Plantation, Florida, April 15, 2021 — OTC PR WIRE — Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing

Link Reservations Inc./LinkResPet (LRSV) Launches Functional Mushroom Product

London, UK, April 14, 2021 – OTC PR WIRE — Link Reservations Inc. (OTC Pink: LRSV) (the “Company”), a provider of wellness and cannabidiol (CBD) products for both humans and pets, announces the launch of DailyLife CBD Immune, its immune boosting functional mushroom product. Featuring a combination of CBD and a spectrum of functional mushrooms

Epidemiologic Solutions Corporation (ESC), an IRS approved, qualified public charity, announces its funding for its “pain-free-veterans” initiative

  Westlake, LA, April 14, 2021 – OTC PR WIRE –  Epidemiologic Solutions Corporation (ESC), a public charity qualified by the Internal Revenue Service pursuant to Section 501(c)(3) commits not less than $200,000 of funding to Gold River Productions Services (OTC Pink: GRPS) for its development of PainplexTM an all-herbal extraction developed by Gold River

PAOG Announces Opportunity To Expand CBD Pharmaceutical Research

  Sandusky, OH, April 13, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today released a management update on the company’s ongoing CBD Pharmaceutical Development Program. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived

SIBANNAC, INC. ANNOUNCES ENTRY INTO MEMORANDUM OF UNDERSTANDING TO ACQUIRE STELLAR CHEMICAL CORP.

  Scottsdale, Arizona, April 12, 2021 – OTC PR WIRE – Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following: Sibannac, Inc. and Stellar Chemical Corp. (“Stellar”), a New Jersey based nutraceutical and industrial chemical manufacturer, have entered into a Memorandum of Understanding for Sibannac to acquire 51% of Stellar in

PAOG Advances CBD Pharmaceutical Developments Backed By US Patent

  Sandusky, OH, April 8, 2021 – OTC PR WIRE —  PAO Group, Inc. (OTC Pink: PAOG) today announced a management update on the company’s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is

Gold River Productions, Inc. (GRPS) announces its initial product line for physicians and its newly-initiated physician-patient distribution network

  Palm Coast, FL, April 5, 2021, Gold River Productions, Inc. (OTC Pink: GRPS) announces today its initial product line for physicians and its newly-initiated physician-patient distribution network. With RushNet Inc.’s (OTC Pink: RSHN) recent acquisition of HeliosDX, the Company isfortunate to share an expanding network of physicians through whom they will be marketing most of their products.

Nutra Pharma Announces Distribution of Luxury Feet for the Relief of Pain from High Heels

Nutra Pharma is announcing the marketing and distribution plans for Luxury Feet; an over-the-counter pain reliever for women who experience pain or discomfort due to high heels and stilettos   Plantation, Florida, March 16, 2021 — OTC PR WIRE — Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine

PURA and PAOG Confirm Ongoing And Expanding Cannabis Partnership

  Dallas, TX, March 11, 2021 – Puration, Inc. (OTC Pink: PURA) and PAOG Group, Inc. (OTC Pink: PAOG) today confirmed the two companies continue to work together on developing a variety of cannabis centric applications through a partnership that initiated when PAOG acquired PURA’s cannabis cultivation business last year.     The PURA and

Nutra Pharma Engages Quality and Regulatory Professionals Ahead of Clinical Trials

  Nutra Pharma is providing updates on their work in improving capabilities and certifications in their laboratory for drug production and validation in preparation of expanded OTC sales and clinical trials   Plantation, Florida,  March 11, 2021 — OTC PR WIRE — Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away

Recent Posts

Recent Posts

Contact Us

All Rights Reserved © 2019